Antitrust & Trade Regulation

Weekly Summaries Distributed July 23, 2015 King Drug Co of Florence Inc, v. Smithkline Beecham Corp. Antitrust & Trade Regulation, Consumer Law, Drugs & Biotech, Patents  U.S. Court of Appeals for the Third Circuit Sioux Pharm, Inc. v. Eagle Labs., Inc. Antitrust & Trade Regulation  Iowa Supreme Court Ward v. Apple, Inc. Antitrust & Trade Regulation, Civil Procedure  U.S. Court of Appeals for the Ninth Circuit United States v. Apple, Inc. Antitrust & Trade Regulation  U.S. Court of Appeals for the Second Circuit Joseph Gen. Contracting, Inc. v. Couto Antitrust & Trade Regulation, Construction Law, Contracts  Connecticut Supreme Court Artie's Auto Body, Inc. v. Hartford Fire Ins. Co. Antitrust & Trade Regulation  Connecticut Supreme Court

Receive this and other FREE daily opinion summaries from Justia

King Drug Co of Florence Inc, v. Smithkline Beecham Corp. Court: U.S. Court of Appeals for the Third Circuit Docket: 14-1243 Opinion Date: June 26, 2015 Areas of Law: Antitrust & Trade Regulation, Consumer Law, Drugs & Biotech, Patents In earlier litigation, Teva challenged the validity and enforceability of GSK’s patents on lamotrigine, Lamictal’s active ingredient. Teva was first to file an FDA application, alleging invalidity or nonenforceability, and seeking approval to produce generic lamotrigine tablets and chewable tablets for markets alleged to be annually worth $2 billion and $50 million,. If the patent suit resulted in a determination of invalidity or nonenforceability—or a settlement incorporating such terms—Teva would be statutorily entitled to a 180- day period of market exclusivity, during which time only it and GSK could produce generic lamotrigine tablets. After the judge ruled the patent’s main claim invalid, the companies settled; Teva would end its patent challenge in exchange for early entry into the chewables market and GSK’s commitment not to produce its own, “authorized generic” Lamictal tablets. Plaintiffs, direct purchasers of Lamictal, sued under the Sherman Act, 15 U.S.C. 1 & 2, claiming that the agreement was a “reverse payment” intended to induce Teva to abandon the patent fight and eliminate the risk of competition in the lamotrigine tablet market for longer than the patent would otherwise permit. The district court dismissed. The Third Circuit vacated, citing Supreme Court precedent, holding that unexplained large payments from the holder of a drug patent to an alleged infringer to settle litigation of the patent’s validity or infringement (reverse payment) can violate antitrust laws. http://j.st/4WQv View Case On: Justia Google Scholar

Sioux Pharm, Inc. v. Eagle Labs., Inc. Court: Iowa Supreme Court Docket: 131525 Opinion Date: June 26, 2015 Areas of Law: Antitrust & Trade Regulation In this battle between two domestic producers of chondroitin sulfate, Plaintiffs filed suit claiming trade-secrets violations against Defendants. Before the Supreme Court was an interlocutory appeal on a discovery issue. The district court entered a protective order requiring the redesignation of Plaintiffs’ standard operating procedures from “attorneys’ eyes only” to “confidential,” which would allow these materials to be disclosed to the defendants themselves. The Supreme Court reversed, holding that, while removing the “attorneys’ eyes only” designation may have been appropriate, the district court’s rationale for ordering redesignation was insufficient. Remanded for further consideration. http://j.st/4Wdc View Case On: Justia Google Scholar

Ward v. Apple, Inc. Court: U.S. Court of Appeals for the Ninth Circuit Docket: 12-17805 Opinion Date: June 29, 2015 Areas of Law: Antitrust & Trade Regulation, Civil Procedure Plaintiffs filed a putative class action against Apple, alleging that Apple conspired with ATTM to violate federal antitrust laws by entering into an exclusivity agreement in which ATTM would be the exclusive provider of voice and data services for Apple's iPhone. The district court dismissed plaintiffs' claims under F.R.C.P. 19 for failure to join ATTM as a defendant. As a preliminary matter, the court determined that it had jurisdiction over the appeal under 28 U.S.C. 1291 because this is an appeal from a final decision of the district court. On the merits, the court concluded that ATTM's role as an antitrust co-conspirator is not alone dispositive of whether it had interests that warrant protection under Rule 19(a)(1)(B)(i). In this case, the district court erred by failing to specify the interests ATTM claimed or to address how those interests might be impaired if the action were resolved in its absence. The court concluded that Apple has not demonstrated that ATTM has a legally protected interest in this action where Apple has not demonstrated that the risk of regulatory scrutiny gives ATTM a legally protected interest in this action; ATTM’s reputational interests in this action are not legally protected under Rule 19; and Apple has not demonstrated that ATTM currently has any substantial contract rights that may be impaired by resolution of this action. Accordingly, the court reversed and remanded. http://j.st/4WPD View Case On: Justia Google Scholar

United States v. Apple, Inc. Court: U.S. Court of Appeals for the Second Circuit Docket: 13-3741 Opinion Date: June 30, 2015 Areas of Law: Antitrust & Trade Regulation The Justice Department and 33 states and territories filed suit alleging that Apple, in launching the iBookstore, had conspired with the Publisher Defendants to raise prices across the nascent ebook market, in violation of section 1 of the Sherman Antitrust Act, 15 U.S.C. 1 et seq., and state antitrust laws. All five Publisher Defendants settled and signed consent decrees, which prohibited them, for a period, from restricting ebook retailers’ ability to set prices. The district court found that the agreement constituted a per se violation of the Sherman Act and, in the alternative, unreasonably restrained trade under the rule of reason. The district court issued an injunctive order that, inter alia, prevents Apple from entering into agreements with the Publisher Defendants that restrict its ability to set, alter, or reduce the price of ebooks, and requires Apple to apply the same terms and conditions to ebook applications sold on its devices as it does to other applications. The court concluded that the district court’s decision that Apple orchestrated a horizontal conspiracy among the Publisher Defendants to raise ebook prices is amply supported and well‐reasoned, and that the agreement unreasonably restrained trade in violation of section 1 of the Sherman Act. The court also concluded that the district court’s injunction is lawful and consistent with preventing future anticompetitive harms. The court rejected Macmillan and Simon & Schuster's argument that the portion of the injunction related to Apple’s pricing authority either unlawfully modifies their consent decrees or should be judicially estopped. Accordingly, the court affirmed the judgment. http://j.st/4WsR View Case On: Justia Google Scholar

Joseph Gen. Contracting, Inc. v. Couto Court: Connecticut Supreme Court Docket:SC19209 Opinion Date: July 21, 2015 Areas of Law: Antitrust & Trade Regulation, Construction Law, Contracts John and Jane Couto entered into a contract with Joseph General Contracting, Inc. for the purchase and construction of a home and carriage house. The trial court found that the contract existed also between the Coutos and Anthony Silvestri, the owner and president of Joseph General. After disputes arose regarding the construction of the dwellings, Joseph General sued the Coutos for, inter alia, breach of contract. The Coutos counterclaimed against Joseph General, Silvestri and Landel Realty, LLC. The trial court held Joseph General, Landel and Silvestri each jointly and severally liable for breach of contract and implied warranty, trespass and violation of the Connecticut Unfair Trade Practices Act (CUTPA). Silvestri appealed the propriety of these adverse rulings with respect to his personal liability. The Appellate Court affirmed the judgment pertaining to Silvestri in an individual capacity. The Supreme Court reversed the judgment of the Appellate Court as to the claims of breach and contract and implied warranty against Silvestri in his individual capacity and affirmed in all other respects, holding that the Appellate Court (1) erred in determining that Silvestri had incurred contractual obligations to the Coutos in his individual capacity; and (2) properly determined that Silvestri could be held individually liable for alleged violations of CUTPA. http://j.st/4WHz View Case On: Justia Google Scholar

Artie's Auto Body, Inc. v. Hartford Fire Ins. Co. Court: Connecticut Supreme Court Docket:SC19219 Opinion Date: July 21, 2015 Areas of Law: Antitrust & Trade Regulation Plaintiffs, automobile body shops and an auto body association, brought this class action against Defendant, The Hartford Fire Insurance Company, on behalf of more than 1,000 independent auto body repair shops in Connecticut, claiming that Defendant violated the Connecticut Unfair Trade Practices Act (CUTPA) by requiring its staff motor vehicle physical damage appraisers to use, when appraising auto body damage sustained by Defendant’s insureds, the hourly labor rates agreed on by Defendant and the plaintiff auto body shops instead of rates that more accurately reflect the actual value of those services. The jury returned a verdict in favor of Plaintiffs, concluding that Defendant’s hourly rate practices constituted an unfair trade practice because they offended the public policy found in section 38a-790-8 of the Regulations of Connecticut State Agencies. The Supreme Court reversed, holding that the trial court incorrectly concluded that section 38a-790-8 supports Plaintiffs’ CUTPA claim alleging unfair labor rate practices. http://j.st/4WHr View Case On: Justia Google Scholar